AstraZeneca, GSK settle long-running UK patent royalty dispute
AstraZeneca and GlaxoSmithKline have settled a dispute over royalty payments owed to AstraZeneca by GlaxoSmithKline subsidiary Tesaro for licenses to the patent for anti-cancer medication niraparib.AstraZeneca and GlaxoSmithKline have settled a...To view the full article, register now.
Already a subscriber? Click here to view full article